Three-Monthly Long-Acting Formulation of Paliperidone Palmitate is a Dominant Treatment Option, Cost Saving While Adding Qalys, Compared to the One-Monthly Formulation in the Treatment of Schizophrenia in France
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.181
https://www.valueinhealthjournal.com/article/S1098-3015(16)31548-0/fulltext
Title :
Three-Monthly Long-Acting Formulation of Paliperidone Palmitate is a Dominant Treatment Option, Cost Saving While Adding Qalys, Compared to the One-Monthly Formulation in the Treatment of Schizophrenia in France
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)31548-0&doi=10.1016/j.jval.2016.09.181
First page :
A378
Section Title :
Research on Methods Studies
Open access? :
No
Section Order :
168